Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?

This publication has 22 references indexed in Scilit:

• Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry
  Metabolism, 1989
• CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPY
  Clinical Endocrinology, 1987
• A radioimmunoassay for bone Gla protein (BGP) in human plasma
  Acta Endocrinologica, 1987
• Bone composition in the distal forearm
  Scandinavian Journal of Clinical and Laboratory Investigation, 1987
• Determination of bone turnover by urinary excretion of 99mTc-MDP
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action
  Metabolism, 1983
• Changes in body composition following therapy of osteoporosis with methandrostenolone
  Metabolism, 1981
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
  European Journal of Clinical Investigation, 1980
• Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass
  Metabolism, 1977
• LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
  The Lancet, 1976